计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| L646246-1mg |
1mg |
期货 ![]() |
| |
| L646246-5mg |
5mg |
期货 ![]() |
| |
| L646246-10mg |
10mg |
期货 ![]() |
| |
| L646246-25mg |
25mg |
期货 ![]() |
|
| 别名 | 醋酸拉唑肽 |
|---|---|
| 英文别名 | F77451 | Larazotide acetate | Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate | UNII-FO8S2IW40N | Larazotide acetate [USAN] | DTXSID401007986 | FO8S2IW40N | D09352 | Q25327025 | Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-gl |
| 规格或纯度 | ≥98% |
| 英文名称 | Larazotide acetate |
| 生化机理 | 醋酸拉拉唑肽是一种多肽,是一种口服活性佐宁拮抗剂。醋酸拉拉唑肽对水痘-带状疱疹病毒(VZV)具有抗病毒活性,对 OKA 株和 07-1 株的 EC 50 s 分别为 44.14 和 59.06 μM。醋酸拉拉唑肽可 |
| 储存温度 | 干燥,-80℃储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 部分激动剂 |
| 作用机制 | 神经元乙酰胆碱受体;α3/β4 部分激动剂 |
| 产品介绍 |
Larazotide acetate is a peptide which is an orally active zonulin antagonist. Larazotide acetate shows antiviral activity to varicella-zoster virus (VZV) with EC 50 s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide acetate can be used for the research of celiac disease and infection . In Vitro Larazotide acetate (1-100 μM; 5 d) affects Vero cell growth. Larazotide acetate (1-100 μM; 3 d) shows antiviral activity to varicella-zoster virus (VZV) with EC 50 s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide acetate (1 and 3 mM; 72 h) inhibits cytokine-induced tight junction permeability in Caco-2 cells. Larazotide acetate (12.5 mM; 1 h) inhibits PTG-induced ZO-1 redistribution and actin cytoskeletal rearrangement in IEC6 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity AssayCell Line: Vero cell line Concentration: 1-100 μM Incubation Time: 5 days Result: Inhibited Vero cell growth with an CC 50 value of 82.5 μM. In Vivo Larazotide acetate (250 μg; i.p. twice a week for 7 weeks) inhibits intestinal permeability in gluten-sensitive transgenic mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: HLA-HCD4/DQ8 double transgenic miceDosage: 250 μg Administration: Intraperitoneal injection; 250 μg twice a week for 7 weeks Result: Improved barrier function parameters and reduced macrophage counts in the lamina propria to control levels. Form:Solid IC50& Target:Paracellular permeability |
| 纯度 | ≥98% |
| 分子类型 | 蛋白质 |
|---|---|
| IIUPAC Name | acetic acid;2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid |
| INCHI | 1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1 |
| InChi Key | NYGCNONRVCGHAT-UFIKZEAMSA-N |
| Smiles | CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN.CC(=O)O |
| Isomeric SMILES | CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CN.CC(=O)O |
| PubChem CID | 44146842 |
| 分子量 | 785.89 |
| 溶解性 | H2O : 16.67 mg/mL (21.21 mM; Need ultrasonic) DMSO : 3.2 mg/mL (4.07 mM; Need ultrasonic and warming) |
|---|---|
| 分子量 | 785.900 g/mol |
| XLogP3 | |
| 氢键供体数Hydrogen Bond Donor Count | 10 |
| 氢键受体数Hydrogen Bond Acceptor Count | 13 |
| 可旋转键计数Rotatable Bond Count | 21 |
| 精确质量Exact Mass | 785.428 Da |
| 单同位素质量Monoisotopic Mass | 785.428 Da |
| 拓扑极表面积Topological Polar Surface Area | 339.000 Ų |
| 重原子数Heavy Atom Count | 55 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1320.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 2 |